International Journal of Cardiology
Volume 125, Issue 2 , Pages 154-160 , 10 April 2008

Outcomes of elderly heart failure recipients of ICD and CRT

  • Wolfram Grimm

      Affiliations

    • Corresponding Author InformationTel.: +49 6421 286 6462; fax: +49 6421 286 8954.

References 

  1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576–1583
  2. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297–1302
  3. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748–754
  4. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med. 1996;335:1933–1940
  5. Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) patch trial investigators. N Engl J Med. 1997;337:1569–1575
  6. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med. 1999;341:1882–1890
  7. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  8. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–2488
  9. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151–2158
  10. Bardy GH, et al. for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237
  11. McAlister FA, Ezekowitz JA, Wiebe N, et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med. 2004;141:381–390
  12. Young JB, et al. for the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289(20):2685–2694
  13. Bristow MR, et al. for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150
  14. Cleland JG, et al. for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–1549
  15. Sheldon R, et al. for the CIDS Investigators Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy. Circulation. 2000;101:1660–1664
  16. Healey JS, Hallstrom AP, Kuck KH, et al. Role of implantable defibrillator among elderly patients with a history of life threatening ventricular arrhythmias. Eur Heart J. 2007;28:1746–1749
  17. Huang DT, Sesselberg HW, Salam T, et al. Survival benefits associated with defibrillator implant in the elderly patients enrolled in MADIT II. Circulation. 2003;1088(Suppl. 17):1790
  18. Grimm W, Stula A, Sharkova J, Maisch B. Outcomes of elderly recipients of implantable cardioverter defibrillators. PACE. 2007;30(Suppl. 1):34–38
  19. Duray G, Richter S, Manegold J, Israel CW, Gronefeld G, Hohnloser SH. Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol. Dec 2005;14(3):169–173
  20. Panotopoulos PT, Axtell K, Anderson AJ, et al. Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol. 1997;29:556–560
  21. Noseworthy PA, Lashevsky I, Dorian P, et al. Feasibility of implantable cardioverter defibrillator use in elderly patients: a case series of octogenarians. PACE. 2004;27:373–378
  22. Ermiz C, Zhu AX, VanHeel L, et al. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival in patients <75 an patients ≥75 years of age treated with implantable cardioverter defibrillators. Europace. 2007;9:270–274
  23. Kovic DZ. Cardiac resynchronization therapy and other new approaches for the treatment of heart failure in the elderly. Am J Geriatr Cardiol. 2006;15:108–113
  24. Schron EB, Exner DV, Yao Q, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105:589–594
  25. Irvine J, Dorian P, Baker B, et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J. 2002;144:282–289
  26. Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace. 2003;5:381–389
  27. Basta LL. End-of-life and other ethical issues related to pacemaker and defibrillator use in the elderly. Am J Geriatr Cardiol. 2006;15:114–117
  28. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141:835–838
  29. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005;353:1471–1480
  30. O'Brien BJ, Connolly SJ, Goeree R, et al. Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS). Circulation. 2001;103:1416–1421
  31. Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J. 2007;28:42–51

PII: S0167-5273(07)01622-1

doi: 10.1016/j.ijcard.2007.10.007

International Journal of Cardiology
Volume 125, Issue 2 , Pages 154-160 , 10 April 2008

Article Tools

* Image Usage & Resolution